TERT and urinary bladder neoplasm: We demonstrated that the TERT C228T mutation was significantly associated with bladder tumor recurrence in the surveillance group, and that ≥14% MAF of TERT C228T, and not just a positive for TERT C228T, was associated with bladder tumor recurrence in pre-TURBT group 1.